(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Neurotensin receptor type 1 Protein (Entity type)	EC50
	(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Neurotensin receptor type 2 Protein (Entity type)	EC50

(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Neurotensin receptor type 1
Protein (Entity type)
EC50

(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Neurotensin receptor type 2
Protein (Entity type)
EC50

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

(S)-5-((S)-1-((S)-2-((S)-1-((S)-1-((S)-1-carboxy-3-methylbutylamino)-3,3-dimethyl-1-oxobutan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-ylamino)-N,N,N,4-tetramethyl-5-oxopentan-1-aminium (Compound)

Analyze

Knowledge Graph Assertions

Knowledge Graph Assertions

Consortium

Community

Resources

Consortium

Community

Resources

Knowledge Graph Assertions